RetiAge
4 papers6 findings
- Humans3
Associations
6Osteoporosis
upin humans1HR 1.12
1 study
Osteoporosis
upin humans1HR 1.12
RetiAge predicts osteoporosis in humans (HR = 1.12, per SD increment, p = 0.001).
“higher RetiAGE predicted future osteoporosis onset (hazard ratio, HR = 1.12, per SD increment, p = 0.001)”
Humansper SD incrementn = 43,938
PLOS digital health14 May 2026
Hip fracture risk score
upin humans1
1 study
Hip fracture risk score
upin humans1
RetiAge is associated with hip fracture risk score in humans (β = 0.29 per SD increment).
“Elevated RetiAGE was associated with an increased risk score of major osteoporotic and hip fractures (β coefficients of 0.48 and 0.29, per SD increment, respectively).”
Humansper SD increment
PLOS digital health14 May 2026
Major osteoporotic fracture risk score
upin humans1
1 study
Major osteoporotic fracture risk score
upin humans1
RetiAge is associated with major osteoporotic fracture risk score in humans (β = 0.48 per SD increment).
“Elevated RetiAGE was associated with an increased risk score of major osteoporotic and hip fractures (β coefficients of 0.48 and 0.29, per SD increment, respectively).”
Humansper SD increment
PLOS digital health14 May 2026
Bone mineral density
downin humans1
1 study
Bone mineral density
downin humans1
RetiAge is associated with bone mineral density in humans (all p < 0.05).
“older RetiAGE was inversely associated with BMD and T-scores in various femoral regions after adjusting for risk factors (all p < 0.05).”
Humansafter adjusting for risk factorsfemur
PLOS digital health14 May 2026
Cataract
upin humans1HR 1.54
1 study
Cataract
upin humans1HR 1.54
RetiAge raises the risk of cataract in humans (HR 1.54 (95% CI 1.38 to 1.73)).
“RetiAge acceleration demonstrated the larger effect size estimates (HR 1.54 (95% CI 1.38 to 1.73))”
Humanslongitudinal cohort
The British journal of ophthalmology8 May 2026
Chronic obstructive pulmonary disease
upin humans1HR 1.6
1 study
Chronic obstructive pulmonary disease
upin humans1HR 1.6
RetiAge raises the risk of chronic obstructive pulmonary disease in humans (HR = 1.60; 95% CI, 1.18-2.19).
“Participants in the moderate-risk and high-risk tertiles of RetiAGE had significantly lower baseline respiratory function (all p < 0.05) and a higher risk of incident COPD (HR = 1.60; 95% CI, 1.18-2.19)”
Humans9.8 ± 0.7 yearsn = 45,438
Clinical & experimental ophthalmology6 Feb 2025